Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.81
-0.79 (-0.86%)
At close: Aug 17, 2026, 4:00 PM EDT
90.81
0.00 (0.00%)
After-hours: Aug 17, 2026, 6:30 PM EDT
Edwards Lifesciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,005 | 1,074 | 4,175 | 1,402 | 1,522 | 1,503 |
Depreciation & Amortization | 165.5 | 156.6 | 143.2 | 122 | 139.6 | 134.8 |
Loss (Gain) From Sale of Assets | -33.9 | -33.9 | -3,348 | - | - | - |
Asset Writedown & Restructuring Costs | 40 | 40 | - | - | 55.1 | 4 |
Loss (Gain) From Sale of Investments | 14.7 | 146.9 | -55 | - | 51.5 | -36.8 |
Stock-Based Compensation | 168 | 158.1 | 162.3 | 139.4 | 126.8 | 109.3 |
Other Operating Activities | 289.9 | -100.6 | -287.3 | -264.6 | -255.3 | -127.6 |
Change in Accounts Receivable | -82.5 | -23 | 121.2 | -141.2 | -84.1 | -91.1 |
Change in Inventory | -15.9 | 50.7 | -256.1 | -289 | -213.4 | 19 |
Change in Accounts Payable | 171.4 | 395.1 | 89.5 | 146 | -21.4 | 195.2 |
Change in Income Taxes | 101.3 | -141.8 | -186.7 | -5.8 | -5.6 | 62 |
Change in Other Net Operating Assets | -103.1 | -126.4 | -27.2 | -236.3 | -96.9 | -39.8 |
Operating Cash Flow | 1,720 | 1,595 | 542.3 | 895.8 | 1,218 | 1,732 |
Operating Cash Flow Growth | 116.42% | 194.16% | -39.46% | -26.46% | -29.67% | 64.29% |
Capital Expenditures | -286.7 | -260.2 | -252.4 | -253 | -244.6 | -325.8 |
Cash Acquisitions | -33.7 | - | -1,062 | -95.2 | - | - |
Divestitures | 42.5 | 42.5 | 3,927 | - | - | - |
Sale (Purchase) of Intangibles | - | - | -30 | -13.3 | -20.2 | -4 |
Investment in Securities | -527.6 | -321.8 | -148.5 | 624.5 | 689.8 | -1,350 |
Other Investing Activities | -106.6 | -173.4 | -121.8 | -89.2 | -172.7 | -42.6 |
Investing Cash Flow | -912.1 | -712.9 | 2,313 | 173.8 | 252.3 | -1,723 |
Long-Term Debt Issued | - | - | - | - | - | 5.2 |
Long-Term Debt Repaid | - | - | - | - | - | -7 |
Net Debt Issued (Repaid) | - | - | - | - | - | -1.8 |
Issuance of Common Stock | 189.7 | 174.1 | 179.5 | 169.9 | 146.4 | 158.6 |
Repurchase of Common Stock | -1,154 | -893.4 | -1,159 | -879.6 | -1,727 | -512.8 |
Other Financing Activities | -238.3 | -237.5 | -3.1 | -1.3 | -3.8 | -0.3 |
Financing Cash Flow | -1,203 | -956.8 | -983 | -711 | -1,585 | -356.3 |
Foreign Exchange Rate Adjustments | 14.5 | -44.8 | 38.6 | 16.8 | 19.2 | 13.9 |
Net Cash Flow | -380.3 | -119.3 | 1,911 | 375.4 | -94.8 | -332.8 |
Free Cash Flow | 1,434 | 1,335 | 289.9 | 642.8 | 973.6 | 1,406 |
Free Cash Flow Growth | 143.85% | 360.50% | -54.90% | -33.98% | -30.77% | 117.26% |
Free Cash Flow Margin | 22.01% | 22.00% | 5.33% | 12.83% | 21.81% | 26.88% |
Free Cash Flow Per Share | 2.47 | 2.28 | 0.48 | 1.05 | 1.56 | 2.23 |
Levered Free Cash Flow | 1,232 | 1,170 | 1,339 | 566.93 | 776.73 | 1,009 |
Unlevered Free Cash Flow | 1,245 | 1,182 | 1,351 | 577.93 | 788.73 | 1,020 |
Cash Interest Paid | 20.2 | 20.2 | 19.6 | 19.9 | 19.3 | 20.2 |
Cash Income Tax Paid | 220.1 | 490.4 | 1,166 | 444.9 | 466.7 | 182.5 |
Change in Working Capital | 71.2 | 154.6 | -259.3 | -526.3 | -421.4 | 145.3 |